NCT05221762Active, not recruiting
Accelerated Stress CMR in Coronary Artery Disease
Accelerated Cardiovascular Magnetic Resonance in Coronary Artery Disease
Source: ClinicalTrials.gov · Last updated 2 Jul 2025
Brief summary (registry, in English)
This study will evaluate the diagnostic performance of an accelerated stress CMR protocol, comparing it with that of standard CMR assessment.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 167 (estimated)
- First submitted
- 15 Nov 2021
- Start date
- 1 Jul 2021
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- University of Leicester
- Diseases
- Coronary artery disease
- NCT number
- NCT05221762
What you commit to
- Study type: Observational
- Planned participants: 167
- From 1 Jul 2021 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who have participated in a research study involving an investigational product in the past 12 weeks
Other illness
- Recent acute coronary syndrome (\< 6 months)
- Severe chronic obstructive pulmonary disease
Other
- Severe claustrophobia
- Absolute contraindications to CMR - those with MR conditional or safe devices will be included
- Second-/third-degree atrioventricular block
- Moderate-severe asthma
- Estimated glomerular filtration rate \<30 ml/min/1.73m2
- Women who are pregnant, breast-feeding or of child-bearing potential (premenopausal women)
- Contraindication to iodinated contrast
- Patients unable to understand written English
Who the study is looking for
- Patients aged ≥18 years
- Referred for invasive coronary angiography for investigation of chest pain
- Willing and able to give informed consent
- Willing and able (in the Investigators opinion) to comply with all study requirements.
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study.
- Able to understand written English
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Glenfield Hospital Coordinator of this site? Confirm its status | Leicester | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.